Theranexus (XPAR:ALTHX) YoY EPS Growth : 34.04% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Theranexus YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Theranexus's YoY EPS Growth for the quarter that ended in Dec. 2023 was 34.04%.

Theranexus's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was €-0.41.

Theranexus YoY EPS Growth Historical Data

The historical data trend for Theranexus's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theranexus YoY EPS Growth Chart

Theranexus Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EPS Growth

Get a 7-Day Free Trial

9.36

23.18

-37.95

24.26

29.29

Theranexus Semi-Annual Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
YoY EPS Growth	Get a 7-Day Free Trial												-86.74	24.05	30.44	-10.82	34.04

Theranexus YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Theranexus's YoY EPS Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EPS Growth (A: Dec. 2023 )
=	(Earnings per Share (Diluted) (A: Dec. 2023 )	-	Earnings per Share (Diluted) (A: Dec. 2022 ))	/	\| Earnings per Share (Diluted) (A: Dec. 2022 ) \|
=	(-0.874	-	-1.236)	/	\| -1.236 \|
=	29.29 %

Theranexus's YoY EPS Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY EPS Growth (Q: Dec. 2023 )
=	(Earnings per Share (Diluted) (Q: Dec. 2023 )	-	Earnings per Share (Diluted) (Q: Dec. 2022 ))	/	\| Earnings per Share (Diluted) (Q: Dec. 2022 )) \|
=	(-0.407	-	-0.617)	/	\| -0.617 \|
=	34.04 %

Theranexus YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Theranexus's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Theranexus (XPAR:ALTHX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theranexus SA (XPAR:ALTHX) » Definitions » YoY EPS Growth

Comparable Companies

Traded in Other Exchanges

3VG:Germany

Address

60 avenue Rockefeller, Pepiniere Laennec, Lyon, FRA, 69008

Website

https://www.theranexus.com

Theranexus SA is a France based biopharmaceutical company. It is engaged in developing drug candidates to be used in the treatment of central nervous system (CNS) disorders. The company's therapeutics platform is based on simultaneously targeting neurons and glial cells by creating and developing innovative combinations of two distinct drugs: a CNS drug targeting neuronal activity; and a drug targeting glial cells. The drug candidates of the organization are THN102 to treat excessive daytime sleepiness in Parkinson's disease, THN201 for the treatment of neurocognitive disorders in Alzheimer's disease and THN101 for neuropathic pain.

Theranexus (XPAR:ALTHX) Headlines

No Headlines